BASEL, Switzerland & SUWON, South Korea–(BUSINESS WIRE)–Under the agreement, Alentis and PinotBio will discover and develop next-generation antibody-drug conjugates targeting claudin-1 for oncology.
BASEL, Switzerland & SUWON, South Korea–(BUSINESS WIRE)–Under the agreement, Alentis and PinotBio will discover and develop next-generation antibody-drug conjugates targeting claudin-1 for oncology.